En-min M. Li

Shantou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 200 publications

Retraction Notice to: "Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma" Gastroenterology 2018;154:2137-2151.e1.

Retraction Notice to: "Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma" Gastroenterology 2018;154:2137-2151.e1.

Journal: Gastroenterology

Published: September 03, 2026

CTDP1 governs a Pol II phosphorylation intermediate and coordinates Mediator recruitment, transcription efficiency, and splicing.

CTDP1 governs a Pol II phosphorylation intermediate and coordinates Mediator recruitment, transcription efficiency, and splicing.

Journal: Nucleic acids research

Published: December 11, 2025

Proteomic analysis across Healthy-NAT-Tumor tissues uncovers clinically relevant biological events in esophageal squamous cell carcinoma.

Proteomic analysis across Healthy-NAT-Tumor tissues uncovers clinically relevant biological events in esophageal squamous cell carcinoma.

Journal: Briefings in bioinformatics

Published: December 05, 2025

IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers.

IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers.

Journal: Cancer discovery

Published: June 16, 2025

IL1RAP Antibody-Drug Conjugates Potently Target Primary and Metastatic Diseases in Multiple Oncofusion-Driven Cancers.

IL1RAP Antibody-Drug Conjugates Potently Target Primary and Metastatic Diseases in Multiple Oncofusion-Driven Cancers.

Journal: Cancer discovery

Published: June 16, 2025

Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer.

Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer.

Journal: British journal of cancer

Published: December 04, 2024

Exploring the Allosteric Response of Fascin to Its Inhibitor.

Exploring the Allosteric Response of Fascin to Its Inhibitor.

Journal: The journal of physical chemistry. B

Published: December 02, 2024

Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.

Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.

Journal: International journal of cancer

Published: November 27, 2024

Diagnostic accuracy of breath tests based on volatile organic compounds for cancer: A systematic review and meta-analysis.

Diagnostic accuracy of breath tests based on volatile organic compounds for cancer: A systematic review and meta-analysis.

Journal: Clinical biochemistry

Published: November 04, 2024

Integrating multi-omics to reveal the molecular mechanism of lipid metabolism regulated by a splice variant of Lysyl-oxidase like-2, LOXL2Δ13.

Integrating multi-omics to reveal the molecular mechanism of lipid metabolism regulated by a splice variant of Lysyl-oxidase like-2, LOXL2Δ13.

Journal: Communications biology

Published: October 08, 2024

Covalent Inhibitor Screening for Targeting LOXL2: Studied by Virtual Screening and Experimental Validation.

Covalent Inhibitor Screening for Targeting LOXL2: Studied by Virtual Screening and Experimental Validation.

Journal: Recent patents on anti-cancer drug discovery

Published: September 23, 2024

PAK2 as a therapeutic target in cancer: Mechanisms, challenges, and future perspectives.

PAK2 as a therapeutic target in cancer: Mechanisms, challenges, and future perspectives.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 22, 2024

Showing 1-12 of 200

Last Updated: 09/26/2026